Legorreta Pablo G.
SEC insider (Form 3/4/5 filer). CIK 0001507678. CEO, Chairman of the Board at Royalty Pharma plc (RPRX) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in NEW YORK, NY.
Companies Legorreta Pablo G. has filed insider reports for
- Royalty Pharma plc (RPRX): Director, Officer, CEO, Chairman of the Board
- PROKIDNEY CORP. (PROK): Director, 10% Owner
Legorreta Pablo G.
CIK: 0001507678
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 7, 2026RPRX
Royalty Pharma plc
GiftDirectLP interests in RPI US Partners 2019, LP
30K shares- - Aug 5, 2026RPRX
Royalty Pharma plc
AwardDirect65.2K shares- - May 28, 2026PROK
PROKIDNEY CORP.
AwardDirectDirector stock option (right to buy)
135K shares- - May 6, 2026RPRX
Royalty Pharma plc
AwardDirect143.8K shares- - Feb 11, 2026RPRX
Royalty Pharma plc
AwardDirect157.8K shares- - Nov 5, 2025RPRX
Royalty Pharma plc
AwardDirect36.6K shares- - Aug 8, 2025RPRX
Royalty Pharma plc
GiftDirectLP interests in RPI US Partners 2019, LP
60K shares- - Aug 6, 2025RPRX
Royalty Pharma plc
AwardDirect21.9K shares- - Jun 3, 2025PROK
PROKIDNEY CORP.
OtherIndirect3.8M shares- - Jun 3, 2025PROK
PROKIDNEY CORP.
ConversionIndirect3.8M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  RPRX Royalty Pharma plc | Gift LP interests in RPI US Partners 2019, LP | 30,000 | - | - | Direct |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Award | 65,216 | - | $0 | Direct |
| May 28, 2026 |  PROK PROKIDNEY CORP. | Award Director stock option (right to buy) | 135,000 | - | - | Direct |
| May 6, 2026 | RPRX Royalty Pharma plc | Award | 143,821 | - | $0 | Direct |
| Feb 11, 2026 | RPRX Royalty Pharma plc | Award | 157,828 | - | $0 | Direct |
| Nov 5, 2025 | RPRX Royalty Pharma plc | Award | 36,559 | - | - | Direct |
| Aug 8, 2025 | RPRX Royalty Pharma plc | Gift LP interests in RPI US Partners 2019, LP | 60,000 | - | - | Direct |
| Aug 6, 2025 | RPRX Royalty Pharma plc | Award | 21,901 | - | - | Direct |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | Other | 3,823,996 | - | - | Indirect |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | Conversion | 3,823,996 | - | - | Indirect |
1-10 of 18 transactions